Neue Suche | Kongressdetail
Druckansicht
 
 

Tumor Myeloid Microenvironment Directed Therapeutics Summit 2021

Evvnt Promotion / evvnt
-
16.03.2021 - 18.03.2021  Virtual
Time: 9:00 am - 5:00 pm
 
Kongressthemen
With the explosive excitement and clinical proof of concept utilizing CD47 approaches, 2020 is the year for macrophage development, as we witness greater interest and investment in new work on novel macrophage targets outside of CD47.

Tumor Myeloid Microenvironment Directed Therapeutics Summit is focused on optimizing the potential of immunotherapy, through direct modulation of tumor-resident myeloid populations to retune the microenvironment for improved response rates to therapy.
Kongressorganizer (PCO)
Hanson Wade
Anmerkungen
Brochure: https://go.evvnt.com/701752-3?pid=4832

Speakers: Peter Ellmark, Alligator Bioscience AB, Victoria Smith, Amphivena Therapeutics Inc., Kaiming Ye, Binghamton University, Michael Klichinsky, Carisma Therapeutics and more
 

Anfragen und Anmeldung:

https://go.evvnt.com/701752-0?pid=4832
Frau Aarti Diwan
 
Kategorien
Allgemeinmedizin, Gesundheitsversorgung
Sprache
Englisch
Kongressgebühr
USD 1499.00 - USD 2997.00
Teilnehmer erwartet
1000
Veranstalter Kontakt
83 Great Titchfield Street
W1W 6RH London
Großbritannien
 
"GOING INTERNATIONAL fördert den Zugang zu Aus-, Fort- und Weiterbildung, unabhängig von sozialen, geographischen und nationalen Grenzen."

Hilfswerk AustriaAlumni Club Medizinische Universität WienEuropean Public Health Association (EUPHA)European Health Forum GasteinCharité International AcademySwiss Tropical and Public Health InstituteOÖ Gebietskrankenkasse, Referat für Wissenschaftskooperation Anästhesie in Entwicklungsländern e. V.